1hii
From Proteopedia
| Line 4: | Line 4: | ||
|PDB= 1hii |SIZE=350|CAPTION= <scene name='initialview01'>1hii</scene>, resolution 2.3Å | |PDB= 1hii |SIZE=350|CAPTION= <scene name='initialview01'>1hii</scene>, resolution 2.3Å | ||
|SITE= | |SITE= | ||
| - | |LIGAND= | + | |LIGAND= <scene name='pdbligand=C20:ACETYL-NH-VAL-CYCLOHEXYL-CH2[NCH2CHOH]CH2-BENZYL-VAL-NH-ACETYL'>C20</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene> |
|ACTIVITY= | |ACTIVITY= | ||
| - | |GENE= POL ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id= | + | |GENE= POL ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=11709 Human immunodeficiency virus 2]) |
| + | |DOMAIN= | ||
| + | |RELATEDENTRY= | ||
| + | |RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1hii FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1hii OCA], [http://www.ebi.ac.uk/pdbsum/1hii PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1hii RCSB]</span> | ||
}} | }} | ||
| Line 16: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
| - | 1HII is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/ | + | 1HII is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_2 Human immunodeficiency virus 2]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1HII OCA]. |
==Reference== | ==Reference== | ||
Comparative analysis of the X-ray structures of HIV-1 and HIV-2 proteases in complex with CGP 53820, a novel pseudosymmetric inhibitor., Priestle JP, Fassler A, Rosel J, Tintelnot-Blomley M, Strop P, Grutter MG, Structure. 1995 Apr 15;3(4):381-9. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/7613867 7613867] | Comparative analysis of the X-ray structures of HIV-1 and HIV-2 proteases in complex with CGP 53820, a novel pseudosymmetric inhibitor., Priestle JP, Fassler A, Rosel J, Tintelnot-Blomley M, Strop P, Grutter MG, Structure. 1995 Apr 15;3(4):381-9. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/7613867 7613867] | ||
| - | [[Category: Human immunodeficiency virus | + | [[Category: Human immunodeficiency virus 2]] |
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Gruetter, M G.]] | [[Category: Gruetter, M G.]] | ||
[[Category: Priestle, J P.]] | [[Category: Priestle, J P.]] | ||
| - | [[Category: C20]] | ||
| - | [[Category: SO4]] | ||
[[Category: aspartate protease]] | [[Category: aspartate protease]] | ||
[[Category: hiv]] | [[Category: hiv]] | ||
[[Category: inhibited]] | [[Category: inhibited]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 21:05:33 2008'' |
Revision as of 18:05, 30 March 2008
| |||||||
| , resolution 2.3Å | |||||||
|---|---|---|---|---|---|---|---|
| Ligands: | , | ||||||
| Gene: | POL (Human immunodeficiency virus 2) | ||||||
| Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||
COMPARATIVE ANALYSIS OF THE X-RAY STRUCTURES OF HIV-1 AND HIV-2 PROTEASES IN COMPLEX WITH CGP 53820, A NOVEL PSEUDOSYMMETRIC INHIBITOR
Overview
BACKGROUND: The human immunodeficiency virus (HIV) is the causative agent of acquired immunodeficiency syndrome (AIDS). Two subtypes of the virus, HIV-1 and HIV-2, have been characterized. The protease enzymes from these two subtypes, which are aspartic acid proteases and have been found to be essential for maturation of the infectious particle, share about 50% sequence identity. Differences in substrate and inhibitor binding between these enzymes have been previously reported. RESULTS: We report the X-ray crystal structures of both HIV-1 and HIV-2 proteases each in complex with the pseudosymmetric inhibitor, CGP 53820, to 2.2 A and 2.3 A, respectively. In both structures, the entire enzyme and inhibitor could be located. The structures confirmed earlier modeling studies. Differences between the CGP 53820 inhibitory binding constants for the two enzymes could be correlated with structural differences. CONCLUSIONS: Minor sequence changes in subsites at the active site can explain some of the observed differences in substrate and inhibitor binding between the two enzymes. The information gained from this investigation may help in the design of equipotent HIV-1/HIV-2 protease inhibitors.
About this Structure
1HII is a Single protein structure of sequence from Human immunodeficiency virus 2. Full crystallographic information is available from OCA.
Reference
Comparative analysis of the X-ray structures of HIV-1 and HIV-2 proteases in complex with CGP 53820, a novel pseudosymmetric inhibitor., Priestle JP, Fassler A, Rosel J, Tintelnot-Blomley M, Strop P, Grutter MG, Structure. 1995 Apr 15;3(4):381-9. PMID:7613867
Page seeded by OCA on Sun Mar 30 21:05:33 2008
